RightFit
RecruitingPhase not listed

Cardiogenic Shock Working Group Registry

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Phone or video check-ins

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes."
  • "De-identified clinical variables are collected from medical records and follow-up phone calls."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study collects health information about people with cardiogenic shock, when the heart cannot pump enough blood. It uses medical records and follow-up phone calls from several hospitals to study patient outcomes. Information that could identify patients is removed.

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You must have cardiogenic shock. This means having at least 2 of the signs below at the same time during your hospital stay, or needing the heart support listed below.
  • Cardiac index, a measure of blood pumped by the heart, below 2.2.
  • PAPI, a pressure-based measure of heart function, below 1.0.
  • Cardiac power output, a measure of the heart’s pumping power, at or below 0.6.
  • Low blood pressure: average pressure (MAP) below 60 mmHg or more than 30 mmHg below your usual level; or top-number pressure (SBP) below 90 mmHg or more than 30 mmHg below your usual level.
  • Pulse above 100 beats per minute.
  • Instead of having 2 signs above, you may qualify if you need at least one short-term heart-pumping device or medicine that raises blood pressure or strengthens the heartbeat to keep these measures above the listed limits.
  • If you had heart surgery, you must still meet these rules 72 hours after surgery.

Who can't join

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    Inclusion Criteria: * Patients must have cardiogenic shock. Cardiogenic shock is defined by at least one of the two categories below: 1. At least 2 of the following concurrently at any point during the index hospitalization: * Cardiac Index \< 2.2 * PAPI \< 1.0 * Cardiac Power Output ≤ 0.6 * MAP \< 60mmHg or a \>30mmHg drop in MAP from baseline * SBP \< 90mmHg or a \>30mmHg drop in SBP from baseline * Pulse \> 100 2. Require at least one acute mechanical circulatory support device, vasopressor or inotrope to maintain values above the above target. Post-cardiotomy patients must meet the inclusion criteria 72 hours after their surgery to be included in this registry.

    Study sites (16)

    FL

    • Cleveland Clinic Florida · Weston, FL 33331Jaime Hernandez-Montfort, MD MPH · Study contactJaime Hernandez-Montfort, MD MPH · Principal investigatorMore trials in Weston

    IL

    • Northwestern Medicine · Chicago, IL 60611Esther Vorovich, MD · Study contactEsther Vorovich · Principal investigatorMore trials in Chicago
    • University of Chicago · Chicago, IL 60612Sandeep Nathan, MD · Study contactSandeep Nathan, MD · Principal investigatorMore trials in Chicago

    MA

    ME

    • Maine Medical Center · Portland, ME 04102Andrew Schwartzman, MD · Study contactAndrew Schwartzman, MD · Principal investigatorMore trials in Portland

    NJ

    • Hackensack Meridian Health · Hackensack, NJ 07601Haroon Faraz, MD · Study contactHaroon Faraz, MD · Principal investigatorMore trials in Hackensack

    NY

    • Columbia University Irving Medical Center · New York, NY 10032Justin Fried, MD · Study contactJustin Fried, MD · Principal investigatorMore trials in New York

    OR

    • Providence St. Vincent Heart Clinic · Portland, OR 97225Jacob Abraham, MD · Study contactJacob Abraham, MD · Principal investigatorMore trials in Portland

    PA

    • Allegheny General Hospital · Pittsburgh, PA 15212Manreet Kanwar, MD · Study contactManreet Kanwar, MD · Principal investigatorMore trials in Pittsburgh
    • University Of Pittsburgh Medical Center · Pittsburgh, PA 15261Gavin Hickey, MD · Study contactGavin Hickey, MD · Principal investigatorMore trials in Pittsburgh

    TX

    • Baylor Scott & White Advanced Heart Failure Clinic · Dallas, TX 75201Detlef Wencker, MD · Study contactDetlef Wencker, MD · Principal investigatorMore trials in Dallas
    • University of Texas Medical Branch · Galveston, TX 77555Wissam Khalife, MD · Study contactWissam Khalife · Study contactMore trials in Galveston
    • Houston Methodist Hospital · Houston, TX 77030: Ju H Kim, MD · Study contactJu H Kim, MD · Principal investigatorMore trials in Houston

    VA

    • Inova Health System · Falls Church, VA 22042Shashank Sinha, MD, MSc · Study contactShashank Sinha, MD, MSc · Principal investigatorMore trials in Falls Church

    WA

    • University of Washington Medical Center · Seattle, WA 98195-9472Claudius Mahr, DO · Study contactClaudius Mahr, DO · Principal investigatorMore trials in Seattle